Trial intelligence / Profile preview

Bioequivalence study of ethinyl estradiol + drospirenone film-coated tablets versus Yaz in healthy Thai women under fasting conditions

TCTR20250309002Phase 1Not yet recruiting

Sponsor
Pharmacy Service Center, Faculty of Pharmacy, Chiang Mai University
Start
Jun 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of ethinyl estradiol + drospirenone, ethinyl estradiol and drospirenone in Not applicable (2 arms), sponsored by Pharmacy Service Center, Faculty of Pharmacy, Chiang Mai University. Primary endpoints: Ethinyl estradiol AUC0-t, Ethinyl estradiol AUC0-inf and 3 more. Planned start Jun 2025; status: not yet recruiting.

02

Drugs

ethinyl estradiol + drospirenoneethinyl estradioldrospirenone
03

Conditions

Not applicable

Beyond the preview

Go deeper on TCTR20250309002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250309002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call